Commercialism, choice and consumer protection: regulation of complementary medicines in Australia

Ken J Harvey, Viola S Korczak, Loretta J Marron and David B Newgreen
Med J Aust 2008; 189 (1): . || doi: 10.5694/j.1326-5377.2008.tb01905.x
Published online: 7 July 2008

In reply: We agree with Kotsirilos that the current listing process of the Therapeutic Goods Administration (TGA) provides some protection for consumers by ensuring that complementary medicines (CMs) are manufactured in accordance with good manufacturing practice.

  • Ken J Harvey1
  • Viola S Korczak2
  • Loretta J Marron3
  • David B Newgreen4

  • 1 School of Public Health, La Trobe University, Melbourne, VIC.
  • 2 Choice (Australian Consumers' Association), Sydney, NSW.
  • 3 Brisbane, QLD.
  • 4 Melbourne, VIC.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.